Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13139-16-7

Post Buying Request

13139-16-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13139-16-7 Usage

Chemical Properties

white fine crystalline powder

Uses

N-Boc-L-isoleucine is used to prepare BOC-L-isoleucine hydroxysuccinimide ester by using 1-hydroxybenzotriazole and 1-ethyl-3-<3-(dimethylamino)propyl>carbodiimide hydrochloride.

Check Digit Verification of cas no

The CAS Registry Mumber 13139-16-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,3 and 9 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13139-16:
(7*1)+(6*3)+(5*1)+(4*3)+(3*9)+(2*1)+(1*6)=77
77 % 10 = 7
So 13139-16-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO4/c1-6-7(2)8(9(13)14)12-10(15)16-11(3,4)5/h7-8H,6H2,1-5H3,(H,12,15)(H,13,14)/t7?,8-/m0/s1

13139-16-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1186)  N-(tert-Butoxycarbonyl)-L-isoleucine Hemihydrate  >99.0%(T)

  • 13139-16-7

  • 5g

  • 220.00CNY

  • Detail
  • TCI America

  • (B1186)  N-(tert-Butoxycarbonyl)-L-isoleucine Hemihydrate  >99.0%(T)

  • 13139-16-7

  • 25g

  • 760.00CNY

  • Detail
  • Alfa Aesar

  • (A16021)  N-Boc-L-isoleucine, 98+%   

  • 13139-16-7

  • 1g

  • 206.0CNY

  • Detail
  • Alfa Aesar

  • (A16021)  N-Boc-L-isoleucine, 98+%   

  • 13139-16-7

  • 5g

  • 368.0CNY

  • Detail
  • Alfa Aesar

  • (A16021)  N-Boc-L-isoleucine, 98+%   

  • 13139-16-7

  • 25g

  • 1120.0CNY

  • Detail
  • Aldrich

  • (359653)  Boc-Ile-OH  98%

  • 13139-16-7

  • 359653-25G

  • 903.47CNY

  • Detail

13139-16-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name BOC-L-Isoleucine

1.2 Other means of identification

Product number -
Other names N-Boc-L-isoleucine Hemihydrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13139-16-7 SDS

13139-16-7Synthetic route

L-isoleucine
73-32-5

L-isoleucine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; for 24h;100%
Stage #1: L-isoleucine With sodium hydroxide In 1,4-dioxane; water at 0℃;
Stage #2: di-tert-butyl dicarbonate In 1,4-dioxane; water at 0 - 20℃;
100%
With sodium hydroxide In 1,4-dioxane; water at 0℃;100%
N-Boc-Ile-Merrifield resin

N-Boc-Ile-Merrifield resin

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With trimethyltin(IV) hydroxide In 1,2-dichloro-ethane for 9h; Heating;100%
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

L-isoleucine
73-32-5

L-isoleucine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
In 1,4-dioxane; sodium hydroxide; water at 20℃; for 24h;95%
With hydroxide
With triethylamine In water; N,N-dimethyl-formamide
L-isoleucine
73-32-5

L-isoleucine

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate
75844-68-7

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With dmap; triethylamine In 1,4-dioxane; water for 15h; Ambient temperature;87%
L-isoleucine
73-32-5

L-isoleucine

dimethylsulfonium methylsulfate

dimethylsulfonium methylsulfate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine In water Ambient temperature;80%
L-isoleucine
73-32-5

L-isoleucine

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate
98015-52-2

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; pH=9.5;71%
L-isoleucine
73-32-5

L-isoleucine

tert-Butyl 4-nitrophenyl carbonate
13303-10-1

tert-Butyl 4-nitrophenyl carbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With sodium hydroxide; tert-butyl alcohol
L-isoleucine
73-32-5

L-isoleucine

tert-butyl fluoroformate
18595-34-1

tert-butyl fluoroformate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane
L-isoleucine
73-32-5

L-isoleucine

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate
16965-08-5

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine In tert-butyl alcohol
t-butylpentachlorophenyl carbonate
18942-25-1

t-butylpentachlorophenyl carbonate

L-isoleucine sodium salt

L-isoleucine sodium salt

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine In chloroform; N,N-dimethyl-formamide
L-isoleucine
73-32-5

L-isoleucine

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water for 4h; Ambient temperature;
L-isoleucine
73-32-5

L-isoleucine

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate
50739-44-1

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With pyridine; sodium hydroxide In acetone for 4h; Ambient temperature;
L-isoleucine
73-32-5

L-isoleucine

tert-butyl α-methoxyvinyl carbonate
81616-10-6

tert-butyl α-methoxyvinyl carbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine 1.) dioxane, water, room temp., 30 min, 2.) 20 deg C, 7.5 h; Yield given. Multistep reaction;
L-isoleucine
73-32-5

L-isoleucine

2-((tert-butoxycarbonyloxy)imino)-2-phenylacetonitrile

2-((tert-butoxycarbonyloxy)imino)-2-phenylacetonitrile

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With triethylamine In water; acetone for 5h; Ambient temperature;
(S)-2,2-Dimethyl-4-((S)-1-methyl-prop-2-ynyl)-oxazolidine-3-carboxylic acid tert-butyl ester
160592-97-2

(S)-2,2-Dimethyl-4-((S)-1-methyl-prop-2-ynyl)-oxazolidine-3-carboxylic acid tert-butyl ester

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With dipyridinium dichromate; hydrogen; pyridinium p-toluenesulfonate; platinum(IV) oxide 1.) MeOH, 2.) EtOH, reflux, 3.) DMF; Yield given. Multistep reaction;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 80 percent / Et3N / acetonitrile / 5 h / 5 °C
2: 80 percent / Et3N / H2O / Ambient temperature
View Scheme
picolyl N-Boc-L-isoleucinate
1361400-96-5

picolyl N-Boc-L-isoleucinate

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Conditions
ConditionsYield
With magnesium In methanol at 20℃; for 4h;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

(2RS,3S)-2-amino-3-methylpentanoic acid

(2RS,3S)-2-amino-3-methylpentanoic acid

A

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

B

N-tert-butoxycarbonyl-D-alloisoleucine
13139-16-7, 35264-07-4, 55721-65-8, 55780-90-0, 116194-21-9

N-tert-butoxycarbonyl-D-alloisoleucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 0 - 22℃; pH=9 - 10; Overall yield = 88 %; Overall yield = 0.77 g; diastereoselective reaction;A n/a
B n/a
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

(S)-methyl 2-((2S,3S)-2-((tert-butoxycarbonyl)amino)-3-methylpentanamido)-3-phenylpropanoate
97641-59-3

(S)-methyl 2-((2S,3S)-2-((tert-butoxycarbonyl)amino)-3-methylpentanamido)-3-phenylpropanoate

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate at 20℃; for 0.166667h;
Stage #2: methyl (2S)-2-amino-3-phenylpropanoate hydrochloride at 20℃; for 1h;
100%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetonitrile at 0 - 20℃; for 2h;98%
Stage #1: methyl (2S)-2-amino-3-phenylpropanoate hydrochloride With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; Inert atmosphere;
Stage #2: N-(tert-butyloxycarbonyl)-L-isoleucine With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h; Inert atmosphere;
Stage #3: With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; for 12h; Inert atmosphere;
88%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

N-(tert-butoxycarbonyl)-L-isoleucine N'-methoxy-N'-methylamide
87694-51-7

N-(tert-butoxycarbonyl)-L-isoleucine N'-methoxy-N'-methylamide

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0℃; for 0.25h; Inert atmosphere;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride With 4-methyl-morpholine In dichloromethane at 0 - 25℃; for 14h; Inert atmosphere;
100%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0℃; for 0.25h; Inert atmosphere;
Stage #2: N,O-dimethylhydroxylamine*hydrochloride With 4-methyl-morpholine In dichloromethane at 25℃; for 14h; Inert atmosphere;
100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 2h;91%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-trichloroacetoxyphthalimide
91837-50-2

N-trichloroacetoxyphthalimide

(2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentanoic acid 1,3-dioxo-1,3-dihydro-isoindol-2-yl ester
72449-59-3

(2S,3S)-2-tert-Butoxycarbonylamino-3-methyl-pentanoic acid 1,3-dioxo-1,3-dihydro-isoindol-2-yl ester

Conditions
ConditionsYield
With pyridine In acetonitrile at 22 - 23℃; for 12h; further solvents;100%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

tert-butyl ((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)carbamate
94888-34-3

tert-butyl ((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)carbamate

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With 4-methyl-morpholine; isobutyl chloroformate In 1,2-dimethoxyethane at 0℃; for 0.0333333h;
Stage #2: With ammonia In 1,2-dimethoxyethane; water at 20℃; for 1h; Further stages.;
100%
With ammonium bicarbonate; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In chloroform Ambient temperature;88%
With ammonium bicarbonate; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In chloroform at 20℃; for 12h;80%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N,0-dimethylhydroxylamine
1117-97-1

N,0-dimethylhydroxylamine

N-(tert-butoxycarbonyl)-L-isoleucine N'-methoxy-N'-methylamide
87694-51-7

N-(tert-butoxycarbonyl)-L-isoleucine N'-methoxy-N'-methylamide

Conditions
ConditionsYield
With 4-methyl-morpholine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at -15℃; for 1h;100%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine; N,0-dimethylhydroxylamine With triethylamine at 0℃;
Stage #2: With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine
95%
With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane94%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Thr(Bn)-Leu-Trp-OMe trifluoroacetate

Thr(Bn)-Leu-Trp-OMe trifluoroacetate

Boc-Ile-Thr(Bn)-Leu-Trp-OMe

Boc-Ile-Thr(Bn)-Leu-Trp-OMe

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; dicyclohexyl-carbodiimide In tetrahydrofuran100%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

1-amino-2-propene
107-11-9

1-amino-2-propene

N-tert-butoxycarbonyl-isoleucine-allylamide
1009839-32-0

N-tert-butoxycarbonyl-isoleucine-allylamide

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With 4-methyl-morpholine; isobutyl chloroformate In 1,2-dimethoxyethane at 0℃; for 0.0333333h;
Stage #2: 1-amino-2-propene In 1,2-dimethoxyethane; water at 20℃; for 1h; Further stages.;
100%
With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine; dicyclohexyl-carbodiimide In dichloromethane; N,N-dimethyl-formamide at 25℃; for 20h;95%
(2S,3R)-3-(-3-{(R)-1-[(S)-amino(benzyloxycarbonylmethylcarbamoyl)methyl]-1-methylprop-2-ynyloxy}-4-benzyloxyphenyl)-2-(benzyloxycarbonylmethylamino)-3-(tert-butyldimethylsilanyloxy)propionic acid 4-methoxybenzyl ester
1013210-34-8

(2S,3R)-3-(-3-{(R)-1-[(S)-amino(benzyloxycarbonylmethylcarbamoyl)methyl]-1-methylprop-2-ynyloxy}-4-benzyloxyphenyl)-2-(benzyloxycarbonylmethylamino)-3-(tert-butyldimethylsilanyloxy)propionic acid 4-methoxybenzyl ester

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

C65H82N4O14Si
1013210-60-0

C65H82N4O14Si

Conditions
ConditionsYield
With sodium hydrogencarbonate; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH
1187223-35-3

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH

Conditions
ConditionsYield
Stage #1: Boc-L-homophenylalanine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-leucine; N-tert-butoxycarbonyl-L-phenylalanine Further stages;
100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH
1187223-36-4

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH

Conditions
ConditionsYield
Stage #1: N-tert-butoxycarbonyl-L-leucine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-phenylalanine; Boc-L-homophenylalanine Further stages;
100%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Propargylamine
2450-71-7

Propargylamine

tert-butyl (2S,3S)-3-methyl-1-oxo-1-(prop-2-ynylamino)pentan-2-ylcarbamate
1268671-02-8

tert-butyl (2S,3S)-3-methyl-1-oxo-1-(prop-2-ynylamino)pentan-2-ylcarbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane for 2h; Inert atmosphere; Reflux;100%
With benzotriazol-1-ol; diisopropyl-carbodiimide In dichloromethane at 0 - 20℃; for 16h; Inert atmosphere;98%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-Me-Leu-OBzl p-toluenesulfonic acid salt

N-Me-Leu-OBzl p-toluenesulfonic acid salt

C25H40N2O5

C25H40N2O5

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;100%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-(tert-butoxycarbonyl)-L-isoleucinol
141321-52-0, 141321-53-1, 141321-50-8, 106946-74-1

N-(tert-butoxycarbonyl)-L-isoleucinol

Conditions
ConditionsYield
With borane-THF In tetrahydrofuran at 0 - 20℃; for 5.83333h; Inert atmosphere;99%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 0.5h;
Stage #2: With sodium tetrahydroborate; water In tetrahydrofuran at 0℃; for 0.5h;
90%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With 4-methyl-morpholine; isobutyl chloroformate In tetrahydrofuran at -15℃; for 0.0166667h;
Stage #2: With sodium tetrahydroborate In tetrahydrofuran; water at 15℃; for 0.00833333h; Further stages.;
84%
piperidine
110-89-4

piperidine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-(tert-butyloxycarbonyl)-L-isoleucine piperidide
192821-18-4

N-(tert-butyloxycarbonyl)-L-isoleucine piperidide

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: piperidine With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h;
96%
With dicyclohexyl-carbodiimide In dichloromethane at 23℃;71%
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With PS-carbodiimide; benzotriazol-1-ol In dichloromethane for 0.166667h;
Stage #2: piperidine In dichloromethane at 20℃;
3-Pyrroline
109-96-6

3-Pyrroline

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-3-pyrroline

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-3-pyrroline

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
1,2,3,6-tetrahydropyridine
694-05-3

1,2,3,6-tetrahydropyridine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-1,2,5,6-tetrahydropyridine

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-1,2,5,6-tetrahydropyridine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-Ethylmethylamine
624-78-2

N-Ethylmethylamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-N-ethyl-N-methylamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-N-ethyl-N-methylamine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

methyl-n-propylamine
627-35-0

methyl-n-propylamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-N-methyl-N-propylamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]-N-methyl-N-propylamine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

Cyclopentamine
1003-03-8

Cyclopentamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]cyclopentylamine

N-[N-(tert-butyloxycarbonyl)-L-isoleucyl]cyclopentylamine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

O-benzyl-L-serine allyl ester hydrochloride

O-benzyl-L-serine allyl ester hydrochloride

Boc-L-Ile-L-Ser(Bn)-OAll
694527-70-3

Boc-L-Ile-L-Ser(Bn)-OAll

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; triethylamine In dichloromethane at 0 - 20℃;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

4-fluorophenylhydrazine
371-14-2

4-fluorophenylhydrazine

2-amino-3-methylpentanoic acid N'-(4-fluorophenyl)hydrazide
1148105-78-5

2-amino-3-methylpentanoic acid N'-(4-fluorophenyl)hydrazide

Conditions
ConditionsYield
Stage #1: N-(tert-butyloxycarbonyl)-L-isoleucine With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0℃; for 0.0833333h;
Stage #2: 4-fluorophenylhydrazine In N,N-dimethyl-formamide for 3h;
Stage #3: With sodium hydroxide; trifluoroacetic acid more than 3 stages;
99%
C17H20N2O4
923672-39-3

C17H20N2O4

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

C28H39N3O7
957475-42-2

C28H39N3O7

Conditions
ConditionsYield
With 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

beta-alanine methyl ester hydrochloride

beta-alanine methyl ester hydrochloride

methyl 3-((2S,3S)-2-(tert-butoxycarbonylamino)-3-methylpentanamido)propanoate

methyl 3-((2S,3S)-2-(tert-butoxycarbonylamino)-3-methylpentanamido)propanoate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 20℃; for 1h;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

methyl 3-aminopropanoate hydrochloride
3196-73-4

methyl 3-aminopropanoate hydrochloride

methyl 3-((2S,3S)-2-(tert-butoxycarbonylamino)-3-methylpentanamido)propanoate

methyl 3-((2S,3S)-2-(tert-butoxycarbonylamino)-3-methylpentanamido)propanoate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide for 1h;99%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-(tert-butoxycarbonyl)isoleucine methyl ester
17901-01-8

N-(tert-butoxycarbonyl)isoleucine methyl ester

Conditions
ConditionsYield
In methanol; diethyl ether at 4℃; Methylation;98.5%
In diethyl ether
hexamethylene imine
111-49-9

hexamethylene imine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]hexamethyleneimine

1-[N-(tert-butyloxycarbonyl)-L-isoleucyl]hexamethyleneimine

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In triethylamine; N,N-dimethyl-formamide Ambient temperature;98%
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

(2S,3S)-2-[N-(tert-butoxycarbonyl)amino]-1-imidazol-1-yl-3-methylpentan-1-one
214836-49-4

(2S,3S)-2-[N-(tert-butoxycarbonyl)amino]-1-imidazol-1-yl-3-methylpentan-1-one

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.5h; Substitution;98%
In tetrahydrofuran for 0.5h; Ambient temperature; Yield given;
In dichloromethane at 0℃; for 1h; Schlenk technique; Inert atmosphere;
In tetrahydrofuran at 20℃; for 2h;
N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

L-isoleucine
73-32-5

L-isoleucine

Conditions
ConditionsYield
With tetradecyl(trihexyl)phosphonium bistriflamide; trifluoroacetic acid at 130℃; for 0.166667h; Ionic liquid;98%
With trifluoroacetic acid at 20℃; for 0.25h;

13139-16-7Relevant articles and documents

Highly enantioselective 1,3-dipolar cycloaddition of imino esters with benzofuranone derivatives catalyzed by thiourea?quaternary ammonium salt

Du, Ting,Li, Zhaokun,Zheng, Changwu,Fang, Guosheng,Yu, Longhui,Liu, Jun,Zhao, Gang

, p. 7485 - 7494 (2018)

Highly enantioselective 1, 3-dipolar cycloaddition of 2-arylidene-benzofuran- 3(2H)-ones with imino esters catalyzed by thiourea?quaternary ammonium salts has been developed. This reaction provides efficient construction of a range of chiral spiro[benzofuran-2,3′-pyrrolidine] in high yields (up to 99%) and with good enantioselectivities (up to 99% ee) under mild conditions.

The role of terminal tyrosine residues in the formation of tripeptide nanotubes: a crystallographic insight

Ray, Sudipta,Drew, Michael G.B.,Das, Apurba Kumar,Banerjee, Arindam

, p. 7274 - 7283 (2006)

Terminally protected acyclic tripeptides containing tyrosine residues at both termini self-assemble into nanotubes in crystals through various non-covalent interactions including intermolecular hydrogen bonds. The nanotube has an average internal diameter of 5 ? (0.5 nm) and the tubular ensemble is developed through the hydrogen-bonded phenolic-OH side chains of tyrosine (Tyr) residues [Org. Lett. 2004, 6, 4463]. We have synthesized and studied several tripeptides 3-6 to probe the role of tyrosine residues in nanotube structure formation. These peptides either have only one Tyr residue at N- or C-termini or they have one or two terminally located phenylalanine (Phe) residues. These tripeptides failed to form any kind of nanotubular structure in the solid state. Single crystal X-ray diffraction studies of these peptides 3-6 clearly demonstrate that substitution of any one of the terminal Tyr residues in the Boc-Tyr-X-Tyr-OMe (X=Val or Ile) sequence disrupts the formation of the nanotubular structure indicating that the presence of two terminally located Tyr residues is vital for nanotube formation.

Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors

An, Yunfei,Fan, Haiyan,Han, Jun,Liu, Wenxia,Sun, Bin,Xie, Honglei

, (2021/11/09)

Ergosterol exert the important function in maintaining the fluidity and osmotic pressure of fungal cells, and its key biosynthesis enzymes (Squalene epoxidase, SE; 14 α-demethylase, CYP51) displayed the obvious synergistic effects. Therefore, we expected to discover the novel antifungal compounds with dual-target (SE/CYP51) inhibitory activity. In the progress, we screened the different kinds of potent fragments based on the dual-target (CYP51, SE) features, and the method of fragment-based drug discovery (FBDD) was used to guide the construction of three different series of benzodioxane compounds. Subsequently, their chemical structures were synthesized and evaluated. These compounds displayed the obvious biological activity against the pathogenic fungal strains. Notably, target compounds 10a-2 and 22a-2 possessed the excellent broad-spectrum anti-fungal activity (MIC50, 0.125–2.0 μg/mL) and the activity against drug-resistant strains (MIC50, 0.5–2.0 μg/mL). Preliminary mechanism studies have confirmed that these compounds effectively inhibited the dual-target (SE/CYP51) activity, they could cause fungal rupture and death by blocking the bio-synthetic pathway of ergosterol. Further experiments discovered that compounds 10a-2 and 22a-2 also maintained a certain of anti-fungal effect in vivo. In summary, this study not only provided the new dual-target drug design strategy and method, but also discover the potential antifungal compounds.

Synthesis, characterization and antimicrobial activity of some novel 1-substituted benzimidazole derivatives

Astley, Demet,Isik, Erkut,Yasa, Ihsan,Yuksekdanaci, Seda

, p. 1372 - 1379 (2020/10/06)

Background: Benzimidazole derivatives are an important class of heterocyclic compounds in organic chemistry as they are related to a wide range of biological properties, including antimicrobial activity. Methods: A series of 1-naphthoyl and benzoyl benzimidazole derivatives were synthesised, identified and screened for their antimicrobial activities against a number of different test organisms such as Escherichia coli, Pseudomonas aureginosa, Klebsiella pneumoniae, Staphylococcus aureus, En-terococcus faecalis, Bacillus cereus, Salmonella typhimurium, Candida albicans (yeast). Results and Discussion: Benzimidazole derivatives (3a-d) were synthesised by using 4 different aminoacids. L-methionine, L-isoleucine, D-Phenylysine and L-Phenylamine as starting materials in the study. Experimental studies involve the use of benzimidazole derivatives (3a-d) of the selected amino acids to synthesize the benzoyl and naphthoyl derivatives of benzimidazole (4a-d, 5a-c). The structures of the synthesized compounds were confirmed by spectroscopic analyses (FTIR,1H-NMR,13C-NMR) and elemental analysis. Conclusion: In this study, only one compound (5a) showed a low MIC value against the eukaryotic microorganism C. albicans. The other six compounds showed higher antimicrobial activities against the prokaryotes C. albicans which is a normal flora in the mouth but is one of the organisms that cause infections leading to the weakening of the human immune system. Compound 5a is a can-didate for future alternative antimicrobial drugs against C. albicans infections. In addition, compound 5a has a potential to be used as an inhibitor against P. aureginosa for the treatment of cyst-ic fibrosis.

Rhamnolipid inspired lipopeptides effective in preventing adhesion and biofilm formation of Candida albicans

Jovanovic, Milos,Radivojevic, Jelena,O'Connor, Kevin,Blagojevic, Stevan,Begovic, Biljana,Lukic, Vera,Nikodinovic-Runic, Jasmina,Savic, Vladimir

supporting information, p. 209 - 217 (2019/03/23)

Rhamnolipids are biodegradable low toxic biosurfactants which exert antimicrobial and anti-biofilm properties. They have attracted much attention recently due to potential applications in areas of bioremediation, therapeutics, cosmetics and agriculture, however, the full potential of these versatile molecules is yet to be explored. Based on the facts that many naturally occurring lipopeptides are potent antimicrobials, our study aimed to explore the potential of replacing rhamnose in rhamnolipids with amino acids thus creating lipopeptides that would mimic or enhance properties of the parent molecule. This would allow not only for more economical and greener production but also, due to the availability of structurally different amino acids, facile manipulation of physico-chemical and biological properties. Our synthetic efforts produced a library of 43 lipopeptides revealing biologically more potent molecules. The structural changes significantly increased, in particular, anti-biofilm properties against Candida albicans, although surface activity of the parent molecule was almost completely abolished. Our findings show that the most active compounds are leucine derivatives of 3-hydroxy acids containing benzylic ester functionality. The SAR study demonstrated a further increase in activity with aliphatic chain elongation. The most promising lipopeptides 15, 23 and 36 at 12.5 μg/mL concentration allowed only 14.3%, 5.1% and 11.2% of biofilm formation, respectively after 24 h. These compounds inhibit biofilm formation by preventing adhesion of C. albicans to abiotic and biotic surfaces.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13139-16-7